OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Contents ~Pa e
Reference and Administrative Details ofthe Charity 3 —4
Trustee's Report 5 —22
Statement ofTrustee's responsibilities 23
Independent
auditor's		 report 24-27
Foreword 28
Statement ofFinancial Activities 29
Balance Sheet 30
Statement ofCashflow 31
Statement ofAccounting Policies 32 - 36
Notes to the Financial Statements 37-45

mbers", dunn
-'.the:		 eno d.,A
ril'..'2022':;to:Janua, ',2023:.
Ngozi Lyn Cote - Chair ofCommittee
/ Non-Executive		 Director
Hayley, Wardle Executive Director ofFinance from 1 April 2021
Melanic Johnson Executive Director of Nursing,
Midwifery
and AHPs
Anita Hagon Council ofGovernor Representative from September
2022
Karen White South Tyneside
Public Constituency		 to June 2022
Joyce Welsh South Tyneside
Public Constituency		 from 1 October
2021 until August 2022
Roy McLachlan Non-Executive
Director - from 15August 2022
Angela Thompson Council ofGovernor
Representative		 from September
2022 to August 2023

Total Total
Notes Unrestricted ' Restricted Endowment 2023 2022
Funds Funds Funds Funds . Funds
f000 ' f000 OOOO ROOO OOOO
Income from:-
Donations
&Legacies
Grants
,
Charitable
Activities
Other Trading Activities
Investments
Total Income
=-
'
Expenditure
on		 2,734
0
2,737
2.4
3
9.3
60
5
165
0
0
0:60
0
80
0
3
173
—„:
3,044
,,8
3
3;055
I		 2,349
70
92
81
2,:598
Raising Funds (28) (1) o (27) (59)
Charitable
Activities		 (1,058): (13) 0 (1,069) (1,193)
'Total Expenditure
Net (Loss)IGain on investments 9.1 (234) .(5) 0 (239) ' 87
,. Net Incomer( Expenditure) . ! 1,728 (11), 3 1,720 1,433
Transfer between funds 0 . (3) 0 :0
'
Net movement
in funds		 1,731 (11) 0 1,720 1,433
Reconciliation
ofFunds
Total funds brought
forward		 8,219 17,7 159 8,555 7,122
Total funds carried forward 9,9iO 159 10,275 . 8,555

Total Total
Notes Unrestricted Restricted Endowment 2023 2022
Funds Funds Funds Funds Funds
f000 f000 f000 f000 f000
Non current assets
Investments 9.1,92 3,334 147 0 3,481 3,790
Total non-current
assets		 3,334 147 0 3,481. 3,790
Current assets
Trade and other receivables 10 0 0 44 35
Cash and cash equivalents 6,838 38 159 7,035 5,373
Total current assets 6,882 38 ' 159 7,079 5,408
Current liabilities
Trade and other payables (266) (19) 0 '(285) (643)
Net current assets 6,616 19 159 6,794 4,765
Total net assets 9,950 166 . 159 10,275 . 8,555
Retained funds ofthe Charity
Endowment
Funds		 13.1 0 0 159 159 159
Restricted Income Funds 13.3 0 166 0 166 177
.Unrestricted
Income Funds		 13.5 9,950 0 0 9,950 8,219
Total retained funds ofthe Charity 9,950 166 159 . 10,275 8,555

Year Ended Year Ended
31March 23 31March 22
R'000s' 'K'000s
Net income and expenditure
for the reporting		 period 1,720 1,433,
(Increase) in current debtors (9) (8)
' Investment
income received		 (173) (81)
Net Loss on investments
revaluation		 239 (87)
(Decrease) / Increase
in current creditors		 (358) 494
Net.cash inflow/(outflow)
from operating		 activities - 1,419 . - 1,751
Disposal at sale proceeds values 1,274 219
Acquisitions
at cost		 (1,204) (209)
Inve'stment
income received		 173 81
Net cash inflow/(ouffiow)
from investment		 activities 91
Net cash inflowl(oufflow)
cash and cash		 equivalents 1,552 1,&42
Cash and cash equivalents
at beginning		 ofthe period 5,373 3,531
Cash and cash equivalents
at end ofthe		 period 7035 5,373

,
2 Total Total
Unrestricted Restricted Endowment 2023 2022
Funds Funds Funds Funds Funds
f000 OOOO f000 f000 ' OOOO
2.1,-,Donations
Donations from individuals 147 3' 0 150 214
Donations from charities ' 9 0 0 9 4
Corporate donations CHolCE 2,500 0 0 2,500 2,000
Corporate donations other 10 0 0 10 16
Non corporate donations .11
2,677,		 0
' ""
3'		 0
"'
0		 11
2,680		 12
2,246
Analysis ofdonations from individuals-
f000 received :Number of deposits .
2023 2022 2023 2022
Indivi'duels
giving
Individuals
gMng		 &f1k
& F100		 Sg
75.		 78
78		 26
286		 - '
26
249
Fundraising - voluntary (not via STSFT) 9 50 16 14
Other
Totals		 . 7. . ..
150-,		 . 8
214.		 183
510,		 . 200.,
489,.
Total Total
Unrestricted Restricted Endowment 2023 2022
Funds Funds Funds Funds Funds
OOOO, OOOO OOOO f000 f000
2.2 Legacies
Perioperatlve
+Critical Care		 36 0 0 36 0
Rehab and Elderly Medicine 3 0' 0 3 0
Medical Specialties 6 0 0 6 100
Ophthalmology 11 0 0 11 3
General Pur'p'oses 0 0 1
'		 0
57 0 0 57 103
In total 7legacies were received during 2022/23, ofwhich
1 was a residuary		 sum received re prior years
(2021/22: 6).
2.3 Total donations and legacies 2734=.= . .:3 '
—.0		 2,737 2,349
Total Total
Unrestricted .Restricted Endowment 2023 2022
2.4 Grants Funds
f000,.		 Funds
OOOO		 . Funds
OOOO		 Funds
f000		 Funds
f000
Grants from Charities
Red Sky Foundation 0 0 0 0 70
CHSA - Covid19 Healthcare Support Appeal 60 0 0 60 0
0 60 70

NOTES TO THE FINANCIAL STATEh llENTS (CON TINUED)
Income from 3 Total Total
charitable Unrestricted Restricted Endowment 2023 2022
activities Funds Funds Funds Funds Funds
f000 OOOO f000 OOOO f000
Course and conference fees 80 0 0 80 92
8 different course types were held (2021/22: 8).
Income from 4 Total Total
other trading Unrestricted Restricted Endowment 2023 2022
activities Funds Funds Funds Funds Funds
OOOO OOOO f000 f000 OOOO
Staff lottery 0 0 5
5 0 0,

Total Total
Unrestricted Restricted Endowment 2023 2022
Funds Funds Funds Funds Funds
EOOO EOOO EOOO E000 EOOO
Bought-in services from
Investment
Broker fee
Corporate
Fundraising		 NHS
non'. pay		 (2)
(23)
(c1)'. .
;(26)"		 0
0
(1)
0
. o
o
'(1),0		 .
.		 (2)
(35)
(24)
(20)
.(1.).
'(4)
(27)::(59)'
All traded investment
business		 covering all funds is handled by the Charity's investment broker, Rathbone
Investment
Management Ltd.
Bought-in services relate to salary recharges from STSFTin respect ofmanaging the staff lottery E2k (0.09wte- whole tim
equivalent), (2021/22: E33kcorporate charity fundraiser
post 0.75wte —leaver end December		 2021).
Total Total
Unrestricted Restricted Endowment 2023 2022
Funds Funds Funds. Funds Funds
6.1 Cost ofCharitable
Activities		 EOOO EOOO EOOO EOOO EOOO
Patients' welfare and amenities (293) 0 0 (293) (238)
Course and conference costs (56) 0 0 (56) (65)
Contributions to NHS (506) (11) 0 (517) (646)
Staff welfare and amenities (137) 0 0 (137) (176)
Support and governance costs :(6'4)
(1;056)		 (2)
(13)',
Governance		 0
(66)
0;;(1;069)		 .'(68)
(1;1,93)
6.2 Staff / Patient Course and' Total Total
Welfare and Conference 2023 2022
Amenmes Costs Costs Research Funds Funds
Support and governance cosh .
E000		 EOOO E000 EOOO f000 EOOO
Unrestricted (44) (6) (14) 0 (64) (67)
Restricted -2
(46)		 0
0
(6':(1'4)„-		 . 0
:0:		 " (2)
(1
(66)',,(68)

Analysis of 7 Investment Costs of
total Costs of Management Charitable Governance Total Total
expenditure Fundraising Costs Activities Costs 2023 2022
f000 f000 f000 OOOO OOOO f000
Other (1) 0 (844) 0 (845) (SO0)
Bought-in services from NHS (2) 0 (211) '(4) (217) (311)
Investment
Broker fee		 0 (24) 0 0 (24) (20)
Audit fees - Internal audit 0 0 0 0 0 (4)
provision
Audit fees - external statutory (10) (10) (17)
audit provision
(3) (24) (1,055) (14) (1,096) (1,252)

Traded Non Current Asset Investments: Investments: Investments:
2023 2022
Total Total
OOOO OOOO
Managed
Portfolios
Market value at 1 April 2,729 2,570
Less: Dlsposals atSales Proceeds values (312) (219)
Add: Acquisitions
at cost		 1,204 209
Net unrealised
and realised		 gain / (loss) on sale and revaluation (140) 169
Market value at31 March 3j481 . 2,729
Fixed Interest Fund Holding
Market value at 1 April 1,061 1,143
Less: Dlsposals atSales Proceeds values
Add: Acquisitions
atcost
Net unrealised
and realised gain / (loss) on sale
Market value at 31 March		 and revaluation (962)
0
(99
)
.
0,		 0
0
82
(
)
1,061
Total non current asset Investments 3,481 3,790
Historic costat 3$ March - Managed Portfolios 3,896 4,221
(and Fixed Interest Holding year ending 31 March 2022 only)
Traded Non Current Asset Investments: 31 March 31 March
2023 2022
Total Total
ROOO fooo
vestinents
iste'd:.on;a'I" 'o'riised:St'ock'Exch		 e:-
In the UK 1,487 2,045
Outside the UK 551 183
Unlisted securities:
In the UK 983 1,050
Outside the UK . 460 512
Total 3,'481' -3;790',
Total gross income: 2023 2022
Total Total
f000 oooo
I
'vestmen s listed on'a:reco		 ri e'd-Stock Exch n"e:
In the UK 60 62
Outside the UK 5 0
Unlisted securities:
In the UK 17 11
Outside the UK 8 8
Investments
in a Common
Deposit Fund		 15 0
Current account / short term Interest 68 0
Total 1.73 ,81

NO TES TO THE FINANCIAL S TES TO THE FINANCIAL S TATEMENTS (C ONTINUED)
Analysis of 10 Amounts falling due within one year. 31March 31 March
Trade and other 2023 2022
Receivables KOOO OOOO
Trade receivables 32. 9
.Amounts
due from STSFT		 0 1
Prepayments and accrued hcome 12 25
Total receivables
falling due within one year		 35
Analysis of 11
'		 Cash and cash equivalents 31March 31 March
Cash and Cash 2023 2022
Equivalents OOOO f000
Cash at GBS(and commercial bank 31 March 2022) 6,424 4,849
Notice Deposits (less than 3months) 465 463
Cash held in dealing account with Investment Broker 146 61
Total cash and cash equivalents 7,035 5,373
Analysis of 12 Amounts falling due within one year. 31March 31 March
Trade and other 2023 2022
Payables f000 FOOO
Amounts
due to STSFT		 (104) (583)
Trade payables
Accruals and deferred
income		 (45)
' l36'		 (49)
(i]1
Total payables falling due within one year l 285)
'		 '(643)

Analysis of 13(Continued) 13(Continued)
Funds
Details of 13.3 Restricted Funds Balance Balance
material 1 April Gain on (Loss)on 31 March
funds- 2022 Income Expenditure Transfers Disposals Revaluation 2023
Restrlcted f000 . f000 f000 f000 f000 f000 fOOO
Funds Material funds
Leukaemia
Research		 Legacy 107 5 (2) 0 1 (4) 107
Ortho paedlcs bequest 36 0 0 0 0 (1) 35
Neonatal
Unit Legacy		 13 1 (12) 0 0 0 2
Other designated
funds
Total		 21
'17,7,		 2
'-:8		 0
'(-14).		 . 0
.'0:		 0 (,1')
'(6)'		 ' 22
166
13.4 Description offunds
Leukaemia
Research		 Legacy For leukaemia and lymphoma research.
Orthopaedics
bequest		 Forthe provision ofan operating theatre bed spedlically
designed for people suffering from curvature ofthe spine
Neonatal
Unit legacy		 For South Tyneside neonahs
Details of 13.5 Unrestricted
Furids
material Balance Balance
.funds- 1 April (Loss) on (Loss) on 31 March
Unrestricted 2022 Income Expenditure Transfers Disposals Revaluation 2823
Funds f000 f000 f000 f000 f000 f000 fOOO
Material funds
Medical Equipment purposes 3333 2,320 (323) 0 (45) (65) 5,220
General Purposes 317 266 (128) 0 (4) (6) 445
Paediatrlc department 338 7 (4) 0 (4) (6) 331
NeoNatal
Unit		 324 16 (10) 0 (3) (5) 322
COVID 19 339 66 (184) 0 (4) (6) 211
Rise Above Cancer 170 29 (20) 0 (2) (3) 174
SRH ICCU 158 58 (50) 0 (3) (3) 160
Phoenix Unit - Chemotherapy 131 21 (2) 0 (2) (3) 145
Glaucoma
purposes		 147 4 (3) 0 (2) (3) 143
Maternity
Unit		 140 3 (2) 0 (2) (2) 137
Renal purposes 88 14 (1) 0 (1) (2) 98
Diabetes purposes Legacy 90 2 (1) 0 (1) (2) 88
Pharmacy
department		 81 7 (1) 0 (1) (1) 85
ALS course - Resusc 62 37 -16 0 (1) (2) 80
SEIGeneral Purposes 57 22 (1) 3 0 (1) 80
Clinical Haematology 119 2 (40) 0 (1) (2) 78
Staff Lottery 64 11 (7) 0 (1) (1) 66
SRH Ward D46 Stroke (prev ESB,D41) 87 6 (25) 0 (1) (1) 66
STDH Cardiology
bequests		 66 2 (1) 0 (1) (1) 65
ENT/SALT purposes 82 (1) 0 (1) (1) 60
Orthopaedic
Department		 73 2 (13) 0 (1) (1) 60
SRH Cardiology 58 3 (1) 0 (1) (1) 58
South Tyneslde
Community		 Planned Car 85 10 (16) 0 (1) (1) 57
Thoradc Medidne 52 2 0 0 (1) (1) 52
Gynaecology
purposes		 52 1 0 0 (1) (1) 51
Other
Total Unrestricted		 Funds 1746
8,219		 132
'3;044		 (232)'
0
(20),
'1';082):3.';(105';		 8
..( .)
'(129		 1618
'9;950